LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

article, google, scholar, pubmed, cas, cyclophosphamide, aprepitant, cancer, pharmacokinetics, cypa, patients, clin, pharmacol, drug, usa, information, race, clinical, human, privacy, cookies, content, research, breast, walko, cytochrome, dce, study, pharmacogenomics, access, chapel, hill, analysis, publish, search, chemotherapy, pharmacology, effect, christine, placebo, cypb, activity, ther, waxman, liver, metab, metabolism, division, school, university,

Topics {✒️}

month download article/chapter bristol-myers squibb company cyclophosphamide-induced hemorrhagic cystitis article cancer chemotherapy substrate-activity based approach full article pdf privacy choices/manage cookies related subjects human liver microsomes heyward hull cytochromes p-450 2b breast cancer patients pharmacology article chemotherapy-induced nausea localized breast cancer potential clinical relevance hepatic cytochrome p450 moderately emetogenic chemotherapy doxorubicin 60 mg/m2 potential drug interactions cytochrome p450 2b6 double-blinded cross concentration–time curve mccrea jb catalyzing n-dechloroethylation von moltke ll garsa aa clinically relevant polymorphisms author information authors clinical oncology guideline conditions privacy policy increased cyp3a4 activity cyclophosphamide 600 mg/m2 cdna-expressed activities interindividual hepatic expression accepting optional cookies european economic area altered pk compared pyrosequencing-based screening article log ifosfamide activation based cyp3a activity journal finder publish article walko moderate cyp3a4 inhibitor research resources article cite breast cancer check access instant access

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients
         description:The prodrug cyclophosphamide is metabolized by cytochrome P450(CYP)2B6 to the active metabolite, 4-hydroxycyclophosphamide (4-OH), and by CYP3A4/5 to toxic chloracetaldehyde and 2-dechloroethylcyclophosphamide (DCE). Since aprepitant is a moderate inhibitor of CYP3A4, the study was designed to determine whether its concurrent use alters the pharmacokinetics (PK) of cyclophosphamide. In addition, we sought to determine the effect of race and pharmacogenomics on cyclophosphamide PK. Eighteen patients with localized breast cancer were randomized in this double-blinded cross-over study to receive aprepitant or placebo in addition to cyclophosphamide 600 mg/m2 and doxorubicin 60 mg/m2. Blood samples were collected for both PK analysis of cyclophosphamide and metabolites and pharmacogenomic analysis. Single nucleotide polymorphisms genotyped were CYP3A4*1B, CYP3A5*3, and CYP2B6*6. The geometric mean area under concentration–time curve (AUC0−t μg/mL h) for cyclophosphamide was 282 following aprepitant and 230 following placebo (ratio 1.23; 90% CI 1.13, 1.33). 4-OH AUC0−t (μg/mL h) was 6.80 following aprepitant and 6.96 following placebo (ratio 0.98; 90% CI 0.88, 1.08). DCE AUC0−t (μg/mL h) was 6.76 following aprepitant and 9.37 following placebo (ratio 0.72; 90% CI 0.64, 0.81). Genotype analysis was confounded by race. Race was a significant predictor of DCE lnAUC0−t (P = 0.0169) as African Americans had approximately a 2-fold higher DCE AUC than Caucasians. Aprepitant altered the exposure of cyclophosphamide and DCE but not the active 4-OH metabolite, making it unlikely that aprepitant would change the clinical efficacy of cyclophosphamide. African Americans were also found to have altered PK compared with Caucasian patients.
         datePublished:2012-01-15T00:00:00Z
         dateModified:2012-01-15T00:00:00Z
         pageStart:1189
         pageEnd:1196
         sameAs:https://doi.org/10.1007/s00280-011-1815-5
         keywords:
            Aprepitant
            Cyclophosphamide
            Pharmacokinetics
            Pharmacogenomics
            Oncology
            Pharmacology/Toxicology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-011-1815-5/MediaObjects/280_2011_1815_Fig1_HTML.gif
         isPartOf:
            name:Cancer Chemotherapy and Pharmacology
            issn:
               1432-0843
               0344-5704
            volumeNumber:69
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Christine M. Walko
               affiliation:
                     name:University of North Carolina
                     address:
                        name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
                     name:University of North Carolina
                     address:
                        name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Austin J. Combest
               affiliation:
                     name:University of North Carolina
                     address:
                        name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ivan Spasojevic
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Duke Cancer Institute Clinical Pharmacology Laboratory, Duke University Medical Center, Durham, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Angela Y. C. Yu
               affiliation:
                     name:University of North Carolina
                     address:
                        name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shriya Bhushan
               affiliation:
                     name:University of North Carolina
                     address:
                        name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Heyward Hull
               affiliation:
                     name:UNC School of Pharmacy
                     address:
                        name:Division of Pharmacotherapy and Experimental Therapeutics, UNC School of Pharmacy, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Janelle Hoskins
               affiliation:
                     name:University of North Carolina
                     address:
                        name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Delma Armstrong
               affiliation:
                     name:University of North Carolina
                     address:
                        name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lisa Carey
               affiliation:
                     name:University of North Carolina
                     address:
                        name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
                     name:Lineberger Comprehensive Cancer Center
                     address:
                        name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frances Collicio
               affiliation:
                     name:University of North Carolina
                     address:
                        name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
                     name:Lineberger Comprehensive Cancer Center
                     address:
                        name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Claire Dees
               affiliation:
                     name:University of North Carolina
                     address:
                        name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
                     name:Lineberger Comprehensive Cancer Center
                     address:
                        name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients
      description:The prodrug cyclophosphamide is metabolized by cytochrome P450(CYP)2B6 to the active metabolite, 4-hydroxycyclophosphamide (4-OH), and by CYP3A4/5 to toxic chloracetaldehyde and 2-dechloroethylcyclophosphamide (DCE). Since aprepitant is a moderate inhibitor of CYP3A4, the study was designed to determine whether its concurrent use alters the pharmacokinetics (PK) of cyclophosphamide. In addition, we sought to determine the effect of race and pharmacogenomics on cyclophosphamide PK. Eighteen patients with localized breast cancer were randomized in this double-blinded cross-over study to receive aprepitant or placebo in addition to cyclophosphamide 600 mg/m2 and doxorubicin 60 mg/m2. Blood samples were collected for both PK analysis of cyclophosphamide and metabolites and pharmacogenomic analysis. Single nucleotide polymorphisms genotyped were CYP3A4*1B, CYP3A5*3, and CYP2B6*6. The geometric mean area under concentration–time curve (AUC0−t μg/mL h) for cyclophosphamide was 282 following aprepitant and 230 following placebo (ratio 1.23; 90% CI 1.13, 1.33). 4-OH AUC0−t (μg/mL h) was 6.80 following aprepitant and 6.96 following placebo (ratio 0.98; 90% CI 0.88, 1.08). DCE AUC0−t (μg/mL h) was 6.76 following aprepitant and 9.37 following placebo (ratio 0.72; 90% CI 0.64, 0.81). Genotype analysis was confounded by race. Race was a significant predictor of DCE lnAUC0−t (P = 0.0169) as African Americans had approximately a 2-fold higher DCE AUC than Caucasians. Aprepitant altered the exposure of cyclophosphamide and DCE but not the active 4-OH metabolite, making it unlikely that aprepitant would change the clinical efficacy of cyclophosphamide. African Americans were also found to have altered PK compared with Caucasian patients.
      datePublished:2012-01-15T00:00:00Z
      dateModified:2012-01-15T00:00:00Z
      pageStart:1189
      pageEnd:1196
      sameAs:https://doi.org/10.1007/s00280-011-1815-5
      keywords:
         Aprepitant
         Cyclophosphamide
         Pharmacokinetics
         Pharmacogenomics
         Oncology
         Pharmacology/Toxicology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-011-1815-5/MediaObjects/280_2011_1815_Fig1_HTML.gif
      isPartOf:
         name:Cancer Chemotherapy and Pharmacology
         issn:
            1432-0843
            0344-5704
         volumeNumber:69
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Christine M. Walko
            affiliation:
                  name:University of North Carolina
                  address:
                     name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
                  name:University of North Carolina
                  address:
                     name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Austin J. Combest
            affiliation:
                  name:University of North Carolina
                  address:
                     name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ivan Spasojevic
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Duke Cancer Institute Clinical Pharmacology Laboratory, Duke University Medical Center, Durham, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Angela Y. C. Yu
            affiliation:
                  name:University of North Carolina
                  address:
                     name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shriya Bhushan
            affiliation:
                  name:University of North Carolina
                  address:
                     name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Heyward Hull
            affiliation:
                  name:UNC School of Pharmacy
                  address:
                     name:Division of Pharmacotherapy and Experimental Therapeutics, UNC School of Pharmacy, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Janelle Hoskins
            affiliation:
                  name:University of North Carolina
                  address:
                     name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Delma Armstrong
            affiliation:
                  name:University of North Carolina
                  address:
                     name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lisa Carey
            affiliation:
                  name:University of North Carolina
                  address:
                     name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
                  name:Lineberger Comprehensive Cancer Center
                  address:
                     name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frances Collicio
            affiliation:
                  name:University of North Carolina
                  address:
                     name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
                  name:Lineberger Comprehensive Cancer Center
                  address:
                     name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Claire Dees
            affiliation:
                  name:University of North Carolina
                  address:
                     name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
                  name:Lineberger Comprehensive Cancer Center
                  address:
                     name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Chemotherapy and Pharmacology
      issn:
         1432-0843
         0344-5704
      volumeNumber:69
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of North Carolina
      address:
         name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Duke Cancer Institute Clinical Pharmacology Laboratory, Duke University Medical Center, Durham, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:UNC School of Pharmacy
      address:
         name:Division of Pharmacotherapy and Experimental Therapeutics, UNC School of Pharmacy, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:Lineberger Comprehensive Cancer Center
      address:
         name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:Lineberger Comprehensive Cancer Center
      address:
         name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:Lineberger Comprehensive Cancer Center
      address:
         name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Christine M. Walko
      affiliation:
            name:University of North Carolina
            address:
               name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
            name:University of North Carolina
            address:
               name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Austin J. Combest
      affiliation:
            name:University of North Carolina
            address:
               name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Ivan Spasojevic
      affiliation:
            name:Duke University Medical Center
            address:
               name:Duke Cancer Institute Clinical Pharmacology Laboratory, Duke University Medical Center, Durham, USA
               type:PostalAddress
            type:Organization
      name:Angela Y. C. Yu
      affiliation:
            name:University of North Carolina
            address:
               name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Shriya Bhushan
      affiliation:
            name:University of North Carolina
            address:
               name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:J. Heyward Hull
      affiliation:
            name:UNC School of Pharmacy
            address:
               name:Division of Pharmacotherapy and Experimental Therapeutics, UNC School of Pharmacy, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Janelle Hoskins
      affiliation:
            name:University of North Carolina
            address:
               name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Delma Armstrong
      affiliation:
            name:University of North Carolina
            address:
               name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Lisa Carey
      affiliation:
            name:University of North Carolina
            address:
               name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
            name:Lineberger Comprehensive Cancer Center
            address:
               name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Frances Collicio
      affiliation:
            name:University of North Carolina
            address:
               name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
            name:Lineberger Comprehensive Cancer Center
            address:
               name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:E. Claire Dees
      affiliation:
            name:University of North Carolina
            address:
               name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
            name:Lineberger Comprehensive Cancer Center
            address:
               name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
      name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
      name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
      name:Duke Cancer Institute Clinical Pharmacology Laboratory, Duke University Medical Center, Durham, USA
      name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
      name:UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA
      name:Division of Pharmacotherapy and Experimental Therapeutics, UNC School of Pharmacy, Chapel Hill, USA
      name:Division of Pharmacotherapy and Experimental Therapeutics, Institute of Pharmacogenomics and Individualized Therapy, UNC School of Pharmacy, University of North Carolina, Chapel Hill, USA
      name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
      name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
      name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
      name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
      name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
      name:Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA
      name:Lineberger Comprehensive Cancer Center, Chapel Hill, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(112)

• What's the financial gain of https://www.springernature.com/gp/authors?
• What's the financial intake of https://link.springernature.com/home/?
• https://order.springer.com/public/cart's total income per month
• How much money does https://submission.springernature.com/new-submission/280/3 generate?
• How much revenue does https://www.springernature.com/gp/librarians/licensing/agc/journals produce monthly?
• Financial intake of https://doi.org/10.1200%2FJCO.2006.06.9591
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16717289
• How much does http://scholar.google.com/scholar_lookup?&title=American%20Society%20of%20clinical%20oncology%20guideline%20for%20antiemetics%20in%20oncology%3A%20update%202006&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.06.9591&volume=24&pages=2932-2947&publication_year=2006&author=Kris%2CMG&author=Hesketh%2CPJ&author=Somerfield%2CMR generate monthly?
• Income figures for https://doi.org/10.1200%2FJCO.2005.09.050
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15837996?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20tolerability%20of%20aprepitant%20for%20the%20prevention%20of%20chemotherapy-induced%20nausea%20and%20vomiting%20in%20patients%20with%20breast%20cancer%20after%20moderately%20emetogenic%20chemotherapy&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.09.050&volume=23&pages=2822-2830&publication_year=2005&author=Warr%2CDG&author=Hesketh%2CPJ&author=Gralla%2CRJ&author=Muss%2CHB&author=Herrstedt%2CJ&author=Eisenberg%2CPD?
• How much does https://doi.org/10.1016%2FS0009-9236%2803%2900123-1 rake in every month?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12891225?
• How much money does http://scholar.google.com/scholar_lookup?&title=Effects%20of%20aprepitant%20on%20cytochrome%20P450%203A4%20activity%20using%20midazolam%20as%20a%20probe&journal=Clin%20Pharmacol%20Ther&doi=10.1016%2FS0009-9236%2803%2900123-1&volume=74&pages=150-156&publication_year=2003&author=Majumdar%2CAK&author=McCrea%2CJB&author=Panebianco%2CDL&author=Hesney%2CM&author=Dru%2CJ&author=Constanzer%2CM generate?
• Revenue of https://doi.org/10.1016%2FS0009-9236%2803%2900066-3
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12844131?
• How much money does http://scholar.google.com/scholar_lookup?&title=Effects%20of%20the%20neurokinin%201%20receptor%20antagonist%20aprepitant%20on%20the%20pharmacokinetics%20of%20dexamethasone%20and%20methylprednisolone&journal=Clin%20Pharmacol%20Ther&doi=10.1016%2FS0009-9236%2803%2900066-3&volume=74&pages=17-24&publication_year=2003&author=McCrea%2CJB&author=Majumdar%2CAK&author=Goldberg%2CMR&author=Iwamoto%2CM&author=Gargano%2CC&author=Panebianco%2CDL make?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8242617
• Get to know http://scholar.google.com/scholar_lookup?&title=Differential%20activation%20of%20cyclophosphamide%20and%20ifosphamide%20by%20cytochromes%20P-450%202B%20and%203A%20in%20human%20liver%20microsomes&journal=Cancer%20Res&volume=53&pages=5629-5637&publication_year=1993&author=Chang%2CTKH&author=Weber%2CGF&author=Crespi%2CCL&author=Waxman%2CDJ's earnings
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10348794's financial summary
• http://scholar.google.com/scholar_lookup?&title=Development%20of%20a%20substrate-activity%20based%20approach%20to%20identify%20the%20major%20human%20liver%20P-450%20catalysts%20of%20cyclophosphamide%20and%20ifosfamide%20activation%20based%20on%20cDNA-expressed%20activities%20and%20liver%20microsomal%20P-450%20profiles&journal=Drug%20Metab%20Dispos&volume=27&pages=655-666&publication_year=1999&author=Roy%2CP&author=Yu%2CLJ&author=Crespi%2CCL&author=Waxman%2CDJ's total income per month
• How much does https://doi.org/10.1016%2FS0006-2952%2899%2900410-4 gross monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10692561's revenue stream
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Role%20of%20human%20liver%20microsomal%20CYP3A4%20and%20CYP2B6%20in%20catalyzing%20N-dechloroethylation%20of%20cyclophosphamide%20and%20ifosfamide&journal=Biochem%20Pharmacol&doi=10.1016%2FS0006-2952%2899%2900410-4&volume=59&pages=961-972&publication_year=2000&author=Huang%2CZ&author=Roy%2CP&author=Waxman%2CDJ?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9280407?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Human%20cytochrome%20P450%202B6%3A%20interindividual%20hepatic%20expression%2C%20substrate%20specificity%2C%20and%20role%20in%20procarcinogen%20activation&journal=Drug%20Metab%20Dispos&volume=25&pages=985-993&publication_year=1997&author=Code%2CEL&author=Crespi%2CCL&author=Penman%2CBW&author=Gonzalez%2CFJ&author=Chang%2CTKH&author=Waxman%2CDJ?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10997936's revenue stream
• What's http://scholar.google.com/scholar_lookup?&title=CYP2B6%20mediates%20the%20in%20vitro%20hydroxylation%20of%20bupropion%3A%20potential%20drug%20interactions%20with%20other%20antidepressants&journal=Drug%20Metab%20Dispos&volume=28&pages=1176-1183&publication_year=2000&author=Hesse%2CLM&author=Venkatarkrishnan%2CK&author=Court%2CMH&author=Moltke%2CLL&author=Duan%2CSX&author=Shader%2CRI's gross income?
• What's the income generated by https://doi.org/10.1097%2F00008571-199906000-00004 each month?
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10471061's earnings
• How much money does http://scholar.google.com/scholar_lookup?&title=Human%20CYP2B6%3A%20expression%2C%20inducibility%2C%20and%20catalytic%20activities&journal=Pharmacogenetics&doi=10.1097%2F00008571-199906000-00004&volume=9&pages=295-306&publication_year=1999&author=Gervot%2CL&author=Rochat%2CB&author=Gautier%2CJC&author=Bohnenstengel%2CF&author=Kroemer%2CH&author=Berardinis%2CV make?
• What's the income of https://doi.org/10.1146%2Fannurev.pharmtox.38.1.389?
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9597161
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=In%20vitro%20and%20in%20vivo%20drug%20interaction%20involving%20human%20CYP3A&journal=Annu%20Rev%20Pharmacol%20Toxicol&doi=10.1146%2Fannurev.pharmtox.38.1.389&volume=38&pages=389-430&publication_year=1998&author=Thummel%2CKE&author=Wilkinson%2CGR?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15838656 make?
• http://scholar.google.com/scholar_lookup?&title=Aprepitant%20inhibits%20cyclophosphamide%20bioactivation%20and%20thiotepa%20metabolism&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-005-1005-4&volume=56&pages=370-378&publication_year=2005&author=Jonge%2CME&author=Huitema%2CAD&author=Holtkamp%2CMJ's financial summary
• What's the monthly money flow for https://doi.org/10.1016%2FS0378-4347%2801%2900243-2?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Liquid%20chromatography-tandem%20mass%20spectrometric%20quantitation%20of%20cyclophosphamide%20and%20its%20hydroxy%20metabolite%20in%20plasma%20and%20tissue%20for%20determination%20of%20tissue%20distribution&journal=Chromatogr%20B%20Biomed%20Sci%20Appl&doi=10.1016%2FS0378-4347%2801%2900243-2&volume=759&pages=277-284&publication_year=2001&author=Sadagopan%2CN&author=Cohen%2CL&author=Roberts%2CB?
• Get to know what's the income of https://doi.org/10.1016%2F0378-4347%2895%2900036-I
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7663697?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Quantitation%20of%204-hydroxycyclophosphamide%2Faldophosphamide%20in%20whole%20blood&journal=J%20Chromatogr%20B%20Biomed%20Appl&doi=10.1016%2F0378-4347%2895%2900036-I&volume=667&pages=247-257&publication_year=1995&author=Anderson%2CLW&author=Ludeman%2CSM&author=Colvin%2COM?
• How much income is https://doi.org/10.1186/1471-2350-6-19 earning monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15882469 pull in monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=CYP3A4%20and%20CYP3A5%20genotyping%20by%20pyrosequencing&journal=BMC%20Med%20Genet&doi=10.1186%2F1471-2350-6-19&volume=6&publication_year=2005&author=Garsa%2CAA&author=McLeod%2CHL&author=Marsh%2CS gross monthly?
• What are the earnings of https://doi.org/10.2217%2F14622416.7.7.995?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17054410 gross monthly?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Pyrosequencing-based%20screening%20for%20genetic%20polymorphisms%20in%20cytochrome%20P450%202B6%20of%20potential%20clinical%20relevance&journal=Pharmacogenomics&doi=10.2217%2F14622416.7.7.995&volume=7&pages=995-1002&publication_year=2006&author=Rohrbacher%2CM&author=Kirchhof%2CA&author=Geisslinger%2CG&author=Lotsch%2CJ have monthly?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16100402
• How much does http://scholar.google.com/scholar_lookup?&title=Pyrosequencing%20of%20clinically%20relevant%20polymorphisms&journal=Methods%20Mol%20Biol&volume=311&pages=97-114&publication_year=2005&author=Marsh%2CS&author=King%2CCR&author=Garsa%2CAA net monthly?
• Discover the revenue of https://doi.org/10.1016%2FS0959-8049%2802%2900024-2
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12008196?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Population%20pharmacokinetics%20of%20adjuvant%20cyclophosphamide%2C%20methotrexate%20and%205-fluorouracil%20%28CMF%29&journal=Eur%20J%20Cancer&doi=10.1016%2FS0959-8049%2802%2900024-2&volume=38&pages=1081-1089&publication_year=2002&author=Batey%2CMA&author=Wright%2CJG&author=Azzabi%2CA&author=Newell%2CDR&author=Lind%2CMJ&author=Calvert%2CAH making per month?
• How much does https://doi.org/10.1080%2F10543400701199528 make?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=A%20new%20approach%20for%20outliers%20in%20a%20bioavailability%2Fbioequivalence%20study&journal=J%20Biopharm%20Stat&doi=10.1080%2F10543400701199528&volume=17&pages=393-405&publication_year=2007&author=Jason%2CJ&author=Liao%2CZ have monthly?
• Learn how profitable https://doi.org/10.2165%2F00003088-200038040-00001 is on a monthly basis
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10803453
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Metabolism%20and%20pharmacokinetics%20of%20oxazaphosphorines&journal=Clin%20Pharmacokinet&doi=10.2165%2F00003088-200038040-00001&volume=38&pages=291-304&publication_year=2000&author=Boddy%2CAV&author=Yule%2CSM?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3552204?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Plasma%20pharmacokinetics%20of%20cyclophosphamide%20and%20its%20cytotoxic%20metabolites%20after%20intravenous%20versus%20oral%20administration%20in%20a%20randomized%2C%20crossover%20trial&journal=Cancer%20Res&volume=47&pages=2723-2726&publication_year=1987&author=Struck%2CRF&author=Alberts%2CDS&author=Horne%2CK generate?
• What's the financial intake of https://doi.org/10.1038%2Fclpt.1992.156?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1330397 is on a monthly basis
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Demographic%20factors%20influencing%20cyclosporine%20pharmacokinetic%20parameters%20in%20patients%20with%20uremia%3A%20racial%20differences%20in%20bioavailability&journal=Clin%20Pharmacol%20Ther&doi=10.1038%2Fclpt.1992.156&volume=52&pages=359-371&publication_year=1992&author=Lindholm%2CA&author=Welsh%2CM&author=Alton%2CC have monthly?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Evidence%20of%20increased%20CYP3A4%20activity%20in%20African%20Americans&journal=Clin%20Pharm%20Ther&volume=59&publication_year=1996&author=Lang%2CCC&author=Kinirons%2CMT&author=Robin%2CDR produce monthly?
• What's the income generated by https://doi.org/10.1097%2F00007890-199503150-00016 each month?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Methylprednisolone%20pharmacokinetics%2C%20cortisol%20response%20and%20adverse%20effects%20in%20black%20and%20white%20renal%20transplant%20recipients&journal=Transplantation&doi=10.1097%2F00007890-199503150-00016&volume=59&pages=729-736&publication_year=1995&author=Tornuture%2CKM&author=Biocevich%2CDM&author=Reed%2CK
• What's the profit of https://doi.org/10.3109%2F03602539508998329?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8521748 bring in?
• http://scholar.google.com/scholar_lookup?&title=Clinical%20importance%20of%20hepatic%20cytochrome%20P450%20in%20drug%20metabolism&journal=Drug%20Metab%20Rev&doi=10.3109%2F03602539508998329&volume=27&pages=397-417&publication_year=1995&author=Spatzenegger%2CM&author=Jaeger%2CW's financial summary
• How much profit does https://doi.org/10.1002%2F1097-0142%28197511%2936%3A5%3C1572%3A%3AAID-CNCR2820360506%3E3.0.CO%3B2-T make?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1059500 make?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Cyclophosphamide-induced%20hemorrhagic%20cystitis%20in%20children%20with%20leukemia&journal=Cancer&doi=10.1002%2F1097-0142%28197511%2936%3A5%3C1572%3A%3AAID-CNCR2820360506%3E3.0.CO%3B2-T&volume=36&pages=1572-1576&publication_year=1975&author=Lawrence%2CHJ&author=Simone%2CJ&author=Aur%2CRJ making per month?
• What's the monthly income of https://citation-needed.springer.com/v2/references/10.1007/s00280-011-1815-5?format=refman&flavour=references?
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christine%20M.%20Walko?
• What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christine%20M.%20Walko%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Austin%20J.%20Combest make?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Austin%20J.%20Combest%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ivan%20Spasojevic
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ivan%20Spasojevic%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Angela%20Y.%20C.%20Yu earns monthly
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Angela%20Y.%20C.%20Yu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shriya%20Bhushan produce monthly?
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shriya%20Bhushan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Heyward%20Hull?
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Heyward%20Hull%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Janelle%20Hoskins
• What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Janelle%20Hoskins%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Delma%20Armstrong make?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Delma%20Armstrong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lisa%20Carey pull in?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lisa%20Carey%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Frances%20Collicio produce monthly?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Frances%20Collicio%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20Claire%20Dees?
• What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20Claire%20Dees%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://s100.copyright.com/AppDispatchServlet?title=The%20effect%20of%20aprepitant%20and%20race%20on%20the%20pharmacokinetics%20of%20cyclophosphamide%20in%20breast%20cancer%20patients&author=Christine%20M.%20Walko%20et%20al&contentID=10.1007%2Fs00280-011-1815-5©right=Springer-Verlag&publication=0344-5704&publicationDate=2012-01-15&publisherName=SpringerNature&orderBeanReset=true gross monthly?
• How much does https://citation-needed.springer.com/v2/references/10.1007/s00280-011-1815-5?format=refman&flavour=citation earn?
• How much revenue does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral produce monthly?
• How much revenue does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research produce monthly?
• How much does https://www.springernature.com/gp/products make?
• How much cash flow does https://www.springernature.com/gp/librarians have monthly?
• What's the revenue for https://www.springernature.com/gp/societies?
• https://www.springernature.com/gp/partners's revenue stream
• Learn about the earnings of https://www.springer.com/
• Learn about the earnings of https://www.nature.com/
• How much does https://www.biomedcentral.com/ net monthly?
• Discover the revenue of https://www.palgrave.com/
• Get to know https://www.apress.com/'s earnings
• What's the profit of https://www.springernature.com/gp/legal/ccpa?
• How much does https://www.springernature.com/gp/info/accessibility net monthly?
• Learn about the earnings of https://support.springernature.com/en/support/home
• What's the financial outcome of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
• Monthly income for https://www.springernature.com/

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js